{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:07:50Z","timestamp":1792638470261,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1S62419N"],"award-info":[{"award-number":["1S62419N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.semarthrit.2021.03.012","type":"journal-article","created":{"date-parts":[[2021,3,27]],"date-time":"2021-03-27T19:17:28Z","timestamp":1616872648000},"page":"486-494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Detection of multiple myositis-specific autoantibodies in unique patients with idiopathic inflammatory myopathy: A single centre-experience and literature review"],"prefix":"10.1016","volume":"51","author":[{"given":"Nele","family":"Van Horebeek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Baptiste","family":"Vulsteke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Bossuyt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristl G.","family":"Claeys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doreen","family":"Dillaerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Poesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Lenaerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Van Damme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Blockmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"De Haes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"De Langhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2021.03.012_bib0001","article-title":"Incidence and prevalence of idiopathic inflammatory myopathies in Sweden: a nationwide population-based study","author":"Svensson","year":"2017","journal-title":"Rheumatol (United Kingdom)"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0002","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"EULAR\/ACR Classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0003","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.autrev.2014.08.011","article-title":"Four dermatomyositis-specific autoantibodies-anti-TIF1\u03b3, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort","volume":"13","author":"Bodoki","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0004","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00403-016-1704-1","article-title":"Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets","volume":"309","author":"Merlo","year":"2017","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0005","article-title":"Autoantibodies in myositis","author":"McHugh","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.04.001","article-title":"Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients","author":"Betteridge","year":"2019","journal-title":"J Autoimmun"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0007","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/joim.12451","article-title":"Myositis-specific autoantibodies: an important tool to support diagnosis of myositis","volume":"280","author":"Betteridge","year":"2016","journal-title":"J Intern Med"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0008","first-page":"1508","article-title":"Clinical features of anti-TIF1-\u03b1 antibody-positive dermatomyositis patients are closely associated with coexistent dermatomyositis-specific autoantibodies and anti-TIF1-\u03b3 or anti-mi-2 autoantibodies","volume":"51","author":"Muro","year":"2012","journal-title":"Rheumatol (United Kingdom)"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0009","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s12026-017-8974-3","article-title":"Reflex testing of speckled cytoplasmic patterns observed in routine ANA HEp-2 indirect immunofluorescence with a multiplex anti-synthetase dot-blot assay: a multicentric pilot study","volume":"66","author":"Infantino","year":"2018","journal-title":"Immunol Res"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0010","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00296-016-3494-3","article-title":"Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis","volume":"36","author":"Srivastava","year":"2016","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0011","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.autrev.2014.03.004","article-title":"The clinical phenotype associated with myositis-specific and associated autoantibodies: A meta-analysis revisiting the so-called antisynthetase syndrome","volume":"13","author":"Lega","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0012","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2017-212915","article-title":"Detection of myositis-specific antibodies","volume":"78","author":"Vulsteke","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2018.10.004","article-title":"Autoantibodies in idiopathic inflammatory myopathies: Clinical associations and laboratory evaluation by mono- and multispecific immunoassays","author":"Damoiseaux","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0014","first-page":"1","article-title":"Anti-EJ, anti-MDA5 double-positive chronic clinically amyopathic dermatomyositis: a case report","author":"Takeuchi","year":"2018","journal-title":"Rheumatol Adv Pract"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0015","first-page":"337","article-title":"Rare myositis-specific autoantibody associations among Hungarian patients with idiopathic inflammatory myopathy","volume":"2015","author":"Bodoki","year":"2015","journal-title":"Acta Reumatol Port"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0016","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1172\/JCI116493","article-title":"Reaction of anti-OJ autoantibodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase","volume":"91","author":"Targoff","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0017","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1136\/jnnp-2016-313166","article-title":"Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy","volume":"87","author":"Watanabe","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0018","first-page":"891","article-title":"Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis\/dermatomyositis","volume":"32","author":"Ceribelli","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0019","first-page":"1","article-title":"Myositis-specific autoantibodies are specific for myositis compared to genetic muscle disease","volume":"2","author":"Mammen","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0020","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/art.1780380119","article-title":"Analysis of the Mi-2 autoantigen of dermatomyositis","volume":"38","author":"Nilasena","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0021","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10067-018-4267-z","article-title":"Myositis autoantibody profiles and their clinical associations in Greek patients with inflammatory myopathies","volume":"38","author":"Zampeli","year":"2019","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0022","first-page":"71","article-title":"Evaluation of cancer-associated myositis and scleroderma autoantibodies in breast cancer patients without rheumatic disease","volume":"35","author":"Shah","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0023","first-page":"1","article-title":"Clinical subsets of juvenile dermatomyositis classified by myositis-specific autoantibodies: Experience at a single center in Japan","volume":"0","author":"Iwata","year":"2018","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0024","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3109\/14397595.2014.896494","article-title":"Comparison of radioimmunoprecipitation versus antigen-specific assays for identification of myositis-specific autoantibodies in dermatomyositis patients","volume":"24","author":"Kang","year":"2014","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2016.02.017","article-title":"Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera","volume":"433","author":"Cavazzana","year":"2016","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0026","first-page":"433","article-title":"Anti-transcription intermediary factor 1-gamma autoantibody ELISA development and validation","volume":"53","author":"Aggarwal","year":"2014","journal-title":"Rheumatol (United Kingdom)"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0027","doi-asserted-by":"crossref","DOI":"10.1002\/art.10263","article-title":"Review: Epitope spreading in systemic lupus erythematosus: Identification of triggering peptide sequences","author":"Monneaux","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0028","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1365-3083.2002.01159.x","article-title":"Immunization with peptides from 60 kDa Ro in diverse mouse strains","volume":"56","author":"Scofield","year":"2002","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0029","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1084\/jem.20041367","article-title":"Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy","volume":"201","author":"Casciola-Rosen","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0030","first-page":"1","article-title":"In adult onset myositis, the presence of interstitial lung disease and myositis specific\/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype","volume":"8","author":"Chinoy","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0031","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/mus.24541","article-title":"Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase in patients with immune-mediated myositis and necrotizing myopathy","volume":"52","author":"Limaye","year":"2015","journal-title":"Muscle and Nerve"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0032","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/art.33403","article-title":"Myositis-specific anti-155\/140 autoantibodies target transcription intermediary factor 1 family proteins","volume":"64","author":"Fujimoto","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0033","first-page":"1","article-title":"EULAR \/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups\u00a0: a methodology report","author":"Bottai","year":"2017","journal-title":"RMD Open"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0034","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jns.2018.12.040","article-title":"Myositis-specific autoantibodies in dermatomyositis\/polymyositis with interstitial lung disease","volume":"397","author":"Li","year":"2019","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0035","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s13075-017-1469-8","article-title":"Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study","volume":"19","author":"Yang","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0036","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/rheumatology\/kez092","article-title":"Autoantibodies to Mi-2 alpha and Mi-2 beta in patients with idiopathic inflammatory myopathy","author":"Richards","year":"2019","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0037","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/ard.60.2.116","article-title":"Autoantibody profiles in the sera of European patients with myositis","volume":"60","author":"Brouwer","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0038","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/art.11484","article-title":"Anti-Signal Recognition Particle Autoantibody in Patients with and Patients Without Idiopathic Inflammatory Myopathy","volume":"50","author":"Kao","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0039","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/rheumatology\/kem359","article-title":"Clinical associations of autoantibodies to a p155\/140 kDa doublet protein in juvenile dermatomyositis","volume":"47","author":"Gunawardena","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0040","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.3899\/jrheum.090652","article-title":"Interstitial lung disease associated with anti-PM\/Scl or anti-Aminoacyl-tRNA synthetase autoantibodies: a similar condition?","volume":"37","author":"Lega","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0041","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1007\/s00296-011-1931-x","article-title":"High Frequencies and co-existing of myositis-specific autoantibodies in patients with idiopathic inflammatory myopathies overlapped to rheumatoid arthritis","volume":"32","author":"Nakajima","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0042","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jim.2012.07.019","article-title":"Anti-SAE antibodies in autoimmune myositis: Identification by unlabelled protein immunoprecipitation in an Italian patient cohort","volume":"384","author":"Tarricone","year":"2012","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0043","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/MD.0b013e31827ebba1","article-title":"Correlation of clinicoserologic and pathologic classifications of inflammatory myopathies","volume":"92","author":"Fernandez","year":"2013","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0044","first-page":"130","article-title":"Anti-MDA5 associated dermatomypsitis: expanding the clinincal spectrum","volume":"100","author":"Hall","year":"2013","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0045","doi-asserted-by":"crossref","first-page":"e60442","DOI":"10.1371\/journal.pone.0060442","article-title":"Common and distinct clinical features in adult patients with anti-Aminoacyl-tRNA Synthetase Antibodies: heterogeneity within the syndrome","volume":"8","author":"Hamaguchi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0046","first-page":"223","article-title":"The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies","volume":"92","author":"Rider","year":"2013","journal-title":"Med (United States)"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/290797","article-title":"Anti-MDA5 antibodies in a large mediterranean population of adults with dermatomyositis","volume":"2014","author":"Labrador-Horrillo","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0048","first-page":"6072","article-title":"Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1\u03b3 antibodies in adults with dermatomyositis","volume":"118","author":"Fiorentino","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0049","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0141616","article-title":"Clinical characteristics of anti-3-hydroxy-3-methylglutaryl coenzyme a reductase antibodies in Chinese patients with idiopathic inflammatory myopathies","volume":"10","author":"Ge","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-015-0277-y","article-title":"Inflammatory myopathy with anti-signal recognition particle antibodies: Case series of 100 patients","volume":"10","author":"Suzuki","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0051","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.pathol.2016.03.012","article-title":"Diagnostic performance of a commercial immunoblot assay for myositis antibody testing","volume":"48","author":"Bundell","year":"2016","journal-title":"Pathology"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0052","first-page":"129","article-title":"Autoantibies in adult patients with idiopathic inflammatory myopathies in Buenos Aires","volume":"76","author":"Gomez","year":"2016","journal-title":"Med (Buenos Aires)"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0053","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/jcla.21948","article-title":"A New Immunodot Assay for Multiplex Detection of Autoantibodies in a Cohort of Italian Patients With Idiopathic Inflammatory Myopathies","volume":"30","author":"Tampoia","year":"2016","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0054","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s00296-017-3729-y","article-title":"Comparison of long-term prognosis and relapse of dermatomyositis complicated with interstitial pneumonia according to autoantibodies: anti-aminoacyl tRNA synthetase antibodies versus anti-melanoma differentiation-associated gene 5 antibody","volume":"37","author":"Isoda","year":"2017","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0055","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.rmed.2016.12.014","article-title":"Interstitial lung disease and myositis-specific and associated autoantibodies: Clinical manifestations, survival and the performance of the new ATS\/ERS criteria for interstitial pneumonia with autoimmune features (IPAF)","volume":"123","author":"Mej\u00eda","year":"2017","journal-title":"Respir Med"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0056","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/jdv.14759","article-title":"Distinctive cutaneous and systemic features associated with specific antimyositis antibodies in adults with dermatomyositis: a prospective multicentric study of 117 patients","volume":"32","author":"Best","year":"2018","journal-title":"J Eur Acad Dermatology Venereol"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0057","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s10067-018-4032-3","article-title":"The clinical phenotype of patients positive for antibodies to myositis and myositis-related disorders","volume":"37","author":"Gofrit","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0058","article-title":"Coexistence of anti-HMGCR and anti-MDA5 identified by an unlabeled immunoprecipitation assay in a Chinese patient cohort with myositis","volume":"97","author":"Huang","year":"2018","journal-title":"Med (United States)"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0059","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1007\/s10067-018-4216-x","article-title":"Calcinosis and malignancy are rare in Chinese adult patients with myositis and nuclear matrix protein 2 antibodies identified by an unlabeled immunoprecipitation assay","volume":"97","author":"Wang","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0060","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/14397595.2018.1452353","article-title":"Myositis-specific autoantibodies in Japanese patients with juvenile idiopathic inflammatory myopathies","volume":"29","author":"Ueki","year":"2019","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0061","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-219221","article-title":"Hyperacute muscle weakness in an unusual coexistence of antisignal recognition particle and anti-Mi-2 antibodies","volume":"2017","author":"Akintayo","year":"2017","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0062","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/art.1780390424","article-title":"Coexistence of two antisynthetases in a patient with the antisynthetase syndrome","volume":"39","author":"Gelp\u00ed","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0063","first-page":"e111","article-title":"Coexistence of anti-Jo1 and anti-signal recognition particle antibodies in a polymyositis patient","volume":"15","author":"Melguizo Madrid","year":"2019","journal-title":"Reumatol Cl\u00ednica (English Ed"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0064","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2169\/internalmedicine.51.6566","article-title":"Characterization of dermatomyositis with coexistence of anti-Jo-1 and anti-SRP antibodies","volume":"51","author":"Sugie","year":"2012","journal-title":"Intern Med"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0065","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s10067-010-1394-6","article-title":"An unusual association: Anti-Jo1 and anti-SRP antibodies in the serum of a patient with polymyositis","volume":"29","author":"Vincze","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0066","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jocn.2014.04.031","article-title":"Anti-synthetase syndrome associated with anti PL-12 and anti-Signal recognition particle antibodies and a necrotizing auto-immune myositis","volume":"22","author":"Malkan","year":"2015","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0067","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jneuroim.2014.07.006","article-title":"Clinical and histological findings associated with autoantibodies detected by RNA immunoprecipitation in inflammatory myopathies","volume":"274","author":"Suzuki","year":"2014","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.semarthrit.2021.03.012_bib0068","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/24725625.2016.1253650","article-title":"Coexistence of anti-melanoma differentiation-associated gene 5 and anti-aminoacyl-transfer RNA synthetase antibodies in a patient with dermatomyositis and rapidly progressive and relapsing interstitial lung disease","volume":"1","author":"Naniwa","year":"2017","journal-title":"Mod Rheumatol Case Reports"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017221000421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017221000421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:05:38Z","timestamp":1758733538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017221000421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0049017221000421"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2021.03.012","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection of multiple myositis-specific autoantibodies in unique patients with idiopathic inflammatory myopathy: A single centre-experience and literature review","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2021.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}